Talamo Giampaolo, Sivik Jeffrey, Pandey Manoj K, Mir Muhammad A
Penn State Milton S. Hershey Medical Center, Hershey, USA
Penn State Milton S. Hershey Medical Center, Hershey, USA.
J Oncol Pharm Pract. 2016 Apr;22(2):332-4. doi: 10.1177/1078155214563813. Epub 2014 Dec 15.
Acute pancreatitis is a rare complication of chemotherapy agents. We describe the case of a patient with multiple myeloma who developed acute pancreatitis after treatment with bortezomib, a proteasome inhibitor commonly used in the treatment of this disease. We reviewed the available medical literature on this topic, and found other seven similar cases, all after intravenous bortezomib. Our case is the first one occurring with the subcutaneous route of administration.
